Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Coker

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of Surgical Oncology|June 30, 2022
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma MetastasesAnna K Lawless, David J Coker, Serigne N Lo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experienceFrancis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2024
Technical considerations for isolated limb perfusion: A consensus paperAndrew J Hayes, David J Coker, Lukas Been, et al.
The Lancet. Digital Health|September 29, 2023
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trialScott W Menzies, Christoph Sinz, Michelle Menzies, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of Surgical Oncology|June 30, 2022
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma MetastasesAnna K Lawless, David J Coker, Serigne N Lo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experienceFrancis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 18, 2024
Technical considerations for isolated limb perfusion: A consensus paperAndrew J Hayes, David J Coker, Lukas Been, et al.
The Lancet. Digital Health|September 29, 2023
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trialScott W Menzies, Christoph Sinz, Michelle Menzies, et al.
Pageof 2